BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38415549)

  • 1. The Role of Beclin 1 and HER2 in Colorectal Carcinoma; An Immunohistochemical Study.
    Gadallah MS; Dawood M; Abdou A
    Asian Pac J Cancer Prev; 2024 Feb; 25(2):617-626. PubMed ID: 38415549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CXCR7 in colorectal adenoma and adenocarcinoma: Correlation with clinicopathological parameters.
    Sherif MF; Ismail IM; Ata SMS
    Ann Diagn Pathol; 2020 Dec; 49():151621. PubMed ID: 32949893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic relevance of autophagy-related markers LC3, p62/sequestosome 1, Beclin-1 and ULK1 in colorectal cancer patients with respect to KRAS mutational status.
    Schmitz KJ; Ademi C; Bertram S; Schmid KW; Baba HA
    World J Surg Oncol; 2016 Jul; 14(1):189. PubMed ID: 27444698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Expression of HER2 and SKP2 in Benign and Malignant Colorectal Lesions.
    Moussa M; Badawy A; Helal N; Hegab F; Youssef M; Aboushousha T; Al Faruok L; Elwy D
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2357-2366. PubMed ID: 32856866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beclin 1 expression is closely linked to colorectal carcinogenesis and distant metastasis of colorectal carcinoma.
    Zhang MY; Gou WF; Zhao S; Mao XY; Zheng ZH; Takano Y; Zheng HC
    Int J Mol Sci; 2014 Aug; 15(8):14372-85. PubMed ID: 25196438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy-related Proteins as a Prognostic Factor of Patients With Colorectal Cancer.
    Koustas E; Sarantis P; Theoharis S; Saetta AA; Chatziandreou I; Kyriakopoulou G; Giannopoulou I; Michelli M; Schizas D; Papavassiliou AG; Karamouzis MV
    Am J Clin Oncol; 2019 Oct; 42(10):767-776. PubMed ID: 31517637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membranous or Cytoplasmic HER2 Expression in Colorectal Carcinoma: Evaluation of Prognostic Value Using Both IHC & BDISH.
    Buhmeida A; Assidi M; Al-Maghrabi J; Dallol A; Sibiany A; Al-Ahwal M; Chaudhary A; Abuzenadah A; Al-Qahtani M
    Cancer Invest; 2018 Feb; 36(2):129-140. PubMed ID: 29504811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of TSP50, SERCA2 and IL-8 in Colorectal Adenoma and Carcinoma: Correlation to Clinicopathological Factors.
    Youssef HMK; Radi DA; Abd El-Azeem MA
    Pathol Oncol Res; 2021; 27():1609990. PubMed ID: 34744521
    [No Abstract]   [Full Text] [Related]  

  • 9. Aberration of Nrf2‑Bach1 pathway in colorectal carcinoma; role in carcinogenesis and tumor progression.
    El-Deek HEM; Ahmed AM; Mohammed RAA
    Ann Diagn Pathol; 2019 Feb; 38():138-144. PubMed ID: 30597358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Beclin-1 and microRNA-30a expression with the severity and treatment response of colorectal cancer.
    Liu L; Meng T; Wang QS; Jin HZ; Sun ZQ; Jin B; Fang F; Wang HJ
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive and prognostic implications of 4E-BP1, Beclin-1, and LC3 for cetuximab treatment combined with chemotherapy in advanced colorectal cancer with wild-type KRAS: Analysis from real-world data.
    Guo GF; Wang YX; Zhang YJ; Chen XX; Lu JB; Wang HH; Jiang C; Qiu HQ; Xia LP
    World J Gastroenterol; 2019 Apr; 25(15):1840-1853. PubMed ID: 31057298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of p63 cytoplasmic expression in colorectal cancer. An immunohistochemical study.
    Albasri AM; Elkablawy MA; Ansari IA; Alhujaily AS; Khalil AA
    Saudi Med J; 2019 May; 40(5):432-439. PubMed ID: 31056618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of Cyclin D1 Over-expression in Colorectal Cancer: An Experience from Madinah, Saudi Arabia.
    Albasri AM; Elkablawy MA; Ansari IA; Alhujaily AS
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2471-2476. PubMed ID: 31450922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
    Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
    Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of Beclin-1 predicts favorable prognosis for patients with colorectal cancer.
    Yang Z; Ghoorun RA; Fan X; Wu P; Bai Y; Li J; Chen H; Wang L; Wang J
    Clin Res Hepatol Gastroenterol; 2015 Feb; 39(1):98-106. PubMed ID: 25130795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of autophagy proteins as prognostic biomarkers in colorectal cancer: a meta-analysis.
    Hu D; Huo Y; Xue Y; Feng H; Sun W; Wang H; Wu J; Wang X
    Future Oncol; 2022 Oct; 18(31):3537-3549. PubMed ID: 36189673
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic significance of Beclin-1 expression in colorectal cancer: a meta-analysis.
    Han Y; Xue XF; Shen HG; Guo XB; Wang X; Yuan B; Guo XP; Kuang YT; Zhi QM; Zhao H
    Asian Pac J Cancer Prev; 2014; 15(11):4583-7. PubMed ID: 24969889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer.
    Gao FJ; Chen JY; Wu HY; Shi J; Chen M; Fan XS; Huang Q
    Int J Clin Exp Pathol; 2014; 7(4):1572-9. PubMed ID: 24817953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance.
    Tian X; Yan L; Zhang D; Guan X; Dong B; Zhao M; Hao C
    Oncol Rep; 2016 Oct; 36(4):1829-36. PubMed ID: 27499181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer.
    Meng H; Li W; Boardman LA; Wang L
    BMC Cancer; 2018 Apr; 18(1):433. PubMed ID: 29661177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.